460 related articles for article (PubMed ID: 15071769)
1. Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy.
Benz K; Dötsch J; Rascher W; Stachel D
Pediatr Nephrol; 2004 Jul; 19(7):794-7. PubMed ID: 15071769
[TBL] [Abstract][Full Text] [Related]
2. Ofatumumab in two pediatric nephrotic syndrome patients allergic to rituximab.
Vivarelli M; Colucci M; Bonanni A; Verzani M; Serafinelli J; Emma F; Ghiggeri G
Pediatr Nephrol; 2017 Jan; 32(1):181-184. PubMed ID: 27687621
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome.
Sinha A; Bhatia D; Gulati A; Rawat M; Dinda AK; Hari P; Bagga A
Nephrol Dial Transplant; 2015 Jan; 30(1):96-106. PubMed ID: 25121488
[TBL] [Abstract][Full Text] [Related]
4. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
Iijima K; Sako M; Nozu K; Mori R; Tuchida N; Kamei K; Miura K; Aya K; Nakanishi K; Ohtomo Y; Takahashi S; Tanaka R; Kaito H; Nakamura H; Ishikura K; Ito S; Ohashi Y;
Lancet; 2014 Oct; 384(9950):1273-81. PubMed ID: 24965823
[TBL] [Abstract][Full Text] [Related]
5. Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
Ravani P; Ponticelli A; Siciliano C; Fornoni A; Magnasco A; Sica F; Bodria M; Caridi G; Wei C; Belingheri M; Ghio L; Merscher-Gomez S; Edefonti A; Pasini A; Montini G; Murtas C; Wang X; Muruve D; Vaglio A; Martorana D; Pani A; Scolari F; Reiser J; Ghiggeri GM
Kidney Int; 2013 Nov; 84(5):1025-33. PubMed ID: 23739238
[TBL] [Abstract][Full Text] [Related]
6. Rituximab therapy for steroid-dependent minimal change nephrotic syndrome.
Gilbert RD; Hulse E; Rigden S
Pediatr Nephrol; 2006 Nov; 21(11):1698-700. PubMed ID: 16932900
[TBL] [Abstract][Full Text] [Related]
7. Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome.
Basu B; Preussler S; Sander A; Mahapatra TKS; Schaefer F
BMC Nephrol; 2020 Nov; 21(1):520. PubMed ID: 33256621
[TBL] [Abstract][Full Text] [Related]
8. Rituximab: is replacement of cyclophosphamide and calcineurin inhibitors in steroid-dependent nephrotic syndrome possible?
Dötsch J; Müller-Wiefel DE; Kemper MJ
Pediatr Nephrol; 2008 Jan; 23(1):3-7. PubMed ID: 17899207
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.
Ravani P; Bonanni A; Rossi R; Caridi G; Ghiggeri GM
Clin J Am Soc Nephrol; 2016 Apr; 11(4):710-20. PubMed ID: 26585985
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome.
Kemper MJ; Gellermann J; Habbig S; Krmar RT; Dittrich K; Jungraithmayr T; Pape L; Patzer L; Billing H; Weber L; Pohl M; Rosenthal K; Rosahl A; Mueller-Wiefel DE; Dötsch J
Nephrol Dial Transplant; 2012 May; 27(5):1910-5. PubMed ID: 22076431
[TBL] [Abstract][Full Text] [Related]
11. Human or Chimeric Monoclonal Anti-CD20 Antibodies for Children with Nephrotic Syndrome: A Superiority Randomized Trial.
Ravani P; Colucci M; Bruschi M; Vivarelli M; Cioni M; DiDonato A; Cravedi P; Lugani F; Antonini F; Prunotto M; Emma F; Angeletti A; Ghiggeri GM
J Am Soc Nephrol; 2021 Oct; 32(10):2652-2663. PubMed ID: 34544820
[TBL] [Abstract][Full Text] [Related]
12. Rituximab efficiency in children with steroid-dependent nephrotic syndrome.
Sellier-Leclerc AL; Macher MA; Loirat C; Guérin V; Watier H; Peuchmaur M; Baudouin V; Deschênes G
Pediatr Nephrol; 2010 Jun; 25(6):1109-15. PubMed ID: 20238230
[TBL] [Abstract][Full Text] [Related]
13. Rituximab in steroid-dependent nephrotic syndrome.
El Koumi M
Iran J Kidney Dis; 2013 Nov; 7(6):502-6. PubMed ID: 24241100
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of children with steroid-dependent nephrotic syndrome with rituximab].
Huang J; Du J; Wang S; Xiao L; Zhao X
Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):521-4. PubMed ID: 25224058
[TBL] [Abstract][Full Text] [Related]
15. [Management of idiopathic nephrotic syndrome in childhood].
Peco-Antić A
Srp Arh Celok Lek; 2004; 132(9-10):352-9. PubMed ID: 15794060
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate Mofetil Following Rituximab in Children With Steroid-Resistant Nephrotic Syndrome.
Basu B; Mahapatra TK; Mondal N
Pediatrics; 2015 Jul; 136(1):e132-9. PubMed ID: 26101364
[TBL] [Abstract][Full Text] [Related]
17. New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome.
van Husen M; Kemper MJ
Pediatr Nephrol; 2011 Jun; 26(6):881-92. PubMed ID: 21229269
[TBL] [Abstract][Full Text] [Related]
18. Rituximab for Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome in Adults: A Retrospective, Multicenter Study in Spain.
DaSilva I; Huerta A; Quintana L; Redondo B; Iglesias E; Draibe J; Praga M; Ballarín J; Díaz-Encarnación M;
BioDrugs; 2017 Jun; 31(3):239-249. PubMed ID: 28534103
[TBL] [Abstract][Full Text] [Related]
19. Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases.
Guigonis V; Dallocchio A; Baudouin V; Dehennault M; Hachon-Le Camus C; Afanetti M; Groothoff J; Llanas B; Niaudet P; Nivet H; Raynaud N; Taque S; Ronco P; Bouissou F
Pediatr Nephrol; 2008 Aug; 23(8):1269-79. PubMed ID: 18465150
[TBL] [Abstract][Full Text] [Related]
20. Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab.
Suri M; Tran K; Sharma AP; Filler G; Grimmer J
Int Urol Nephrol; 2008; 40(3):807-10. PubMed ID: 18491215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
